Early impact of maternal RSV vaccination on bronchiolitis hospitalisation and critical care admissions in infants under age 3 months, England, September 2024 to March 2026.
Jonathan Broad, Matthew Wilson, Jaime Borjas-Howard, Merryn Voysey, Simon B Drysdale, Nick Andrews, Conall H Watson, Heather J Whitaker
{"title":"Early impact of maternal RSV vaccination on bronchiolitis hospitalisation and critical care admissions in infants under age 3 months, England, September 2024 to March 2026.","authors":"Jonathan Broad, Matthew Wilson, Jaime Borjas-Howard, Merryn Voysey, Simon B Drysdale, Nick Andrews, Conall H Watson, Heather J Whitaker","doi":"10.2807/1560-7917.ES.2026.31.36.2600752","DOIUrl":null,"url":null,"abstract":"<p><p>We conducted a time series analysis of hospitalisation and critical care admissions to evaluate the impact of maternal respiratory syncytial virus (RSV) vaccination in England from September 2024 to March 2026 in infants < 3 months of age. All bronchiolitis admissions decreased by 39.3% (IRR: 0.607, 95% CI: 0.576-0.640), and RSV bronchiolitis admissions by 62.6% (IRR: 0.374, 95% CI: 0.344-0.407). We estimated a 41.0% reduction in bronchiolitis critical care admissions (IRR: 0.590, 95% CI: 0.531-0.657). Maternal vaccine coverage was 55.1%. These findings support efforts to expand vaccine uptake.</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"31 36","pages":""},"PeriodicalIF":8.3000,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13570235/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eurosurveillance","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2807/1560-7917.ES.2026.31.36.2600752","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
We conducted a time series analysis of hospitalisation and critical care admissions to evaluate the impact of maternal respiratory syncytial virus (RSV) vaccination in England from September 2024 to March 2026 in infants < 3 months of age. All bronchiolitis admissions decreased by 39.3% (IRR: 0.607, 95% CI: 0.576-0.640), and RSV bronchiolitis admissions by 62.6% (IRR: 0.374, 95% CI: 0.344-0.407). We estimated a 41.0% reduction in bronchiolitis critical care admissions (IRR: 0.590, 95% CI: 0.531-0.657). Maternal vaccine coverage was 55.1%. These findings support efforts to expand vaccine uptake.
期刊介绍:
Eurosurveillance is a European peer-reviewed journal focusing on the epidemiology, surveillance, prevention, and control of communicable diseases relevant to Europe.It is a weekly online journal, with 50 issues per year published on Thursdays. The journal includes short rapid communications, in-depth research articles, surveillance reports, reviews, and perspective papers. It excels in timely publication of authoritative papers on ongoing outbreaks or other public health events. Under special circumstances when current events need to be urgently communicated to readers for rapid public health action, e-alerts can be released outside of the regular publishing schedule. Additionally, topical compilations and special issues may be provided in PDF format.